Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5198206
Max Phase: Preclinical
Molecular Formula: C46H70N12O12S2
Molecular Weight: 1047.27
Associated Items:
ID: ALA5198206
Max Phase: Preclinical
Molecular Formula: C46H70N12O12S2
Molecular Weight: 1047.27
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)CSCc2cccc(n2)CSC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)NC1=O
Standard InChI: InChI=1S/C46H70N12O12S2/c1-24(2)15-31-39(63)54-33(17-26-10-12-29(61)13-11-26)41(65)52-32(16-25(3)4)40(64)55-34(18-59)42(66)58-37(44(68)56-35(19-60)45(69)70)23-72-21-28-8-5-7-27(51-28)20-71-22-36(43(67)53-31)57-38(62)30(47)9-6-14-50-46(48)49/h5,7-8,10-13,24-25,30-37,59-61H,6,9,14-23,47H2,1-4H3,(H,52,65)(H,53,67)(H,54,63)(H,55,64)(H,56,68)(H,57,62)(H,58,66)(H,69,70)(H4,48,49,50)/t30-,31-,32-,33-,34-,35-,36-,37-/m0/s1
Standard InChI Key: NZTLEGVFCGIFRH-MDKUUQCZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1047.27 | Molecular Weight (Monoisotopic): 1046.4678 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):